172 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 4 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
LGALS9BGalectin 9BPredicted intracellular proteins
CytosolTissue enhanced
LGALS9CGalectin 9CPredicted intracellular proteins
CytosolTissue enhanced
LINC00675Long intergenic non-protein coding RNA 675Predicted membrane proteins
Tissue enhanced
LINC01207Long intergenic non-protein coding RNA 1207Predicted secreted proteins
Group enriched
LIPHLipase HDisease related genes
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
LRRC19Leucine rich repeat containing 19Predicted membrane proteins
Group enriched
LRRC31Leucine rich repeat containing 31Predicted intracellular proteins
Group enriched
MEP1AMeprin A subunit alphaEnzymes
Plasma proteins
Predicted membrane proteins
Group enriched
MISPMitotic spindle positioningPredicted intracellular proteins
Plasma membrane
Focal adhesion sites
Group enriched
MOGAT2Monoacylglycerol O-acyltransferase 2Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
MOGAT3Monoacylglycerol O-acyltransferase 3Enzymes
Predicted membrane proteins
CentrosomeGroup enriched
MUC13Mucin 13, cell surface associatedPredicted membrane proteins
Predicted secreted proteins
Group enriched
MYBMYB proto-oncogene, transcription factorCancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleus
Plasma membrane
Tissue enhanced
MYO1AMyosin IAPlasma proteins
Predicted intracellular proteins
Group enriched
NAT2N-acetyltransferase 2Cancer-related genes
Enzymes
Predicted intracellular proteins
Group enriched
NEU4Neuraminidase 4Enzymes
Predicted intracellular proteins
Group enriched
NOS2Nitric oxide synthase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
NOXO1NADPH oxidase organizer 1FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
NPY4RNeuropeptide Y receptor Y4G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
NR1I2Nuclear receptor subfamily 1 group I member 2FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmGroup enriched
NXPE2Neurexophilin and PC-esterase domain family member 2Predicted intracellular proteins
Tissue enhanced
NXPE4Neurexophilin and PC-esterase domain family member 4Predicted intracellular proteins
Predicted secreted proteins
Group enriched
OLFM4Olfactomedin 4Predicted secreted proteins
Tissue enhanced
OTOP2Otopetrin 2Predicted membrane proteins
Tissue enhanced
PADI2Peptidyl arginine deiminase 2Enzymes
Predicted intracellular proteins
Tissue enhanced
PAX4Paired box 4Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
Transcription factors
Tissue enhanced
PHGR1Proline, histidine and glycine rich 1Predicted intracellular proteins
VesiclesGroup enriched
PIGZPhosphatidylinositol glycan anchor biosynthesis class ZPredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
PIRTPhosphoinositide interacting regulator of transient receptor potential channelsPredicted membrane proteins
Transporters
Plasma membrane
Cytosol
Tissue enhanced
PLA2G10Phospholipase A2 group XEnzymes
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G2APhospholipase A2 group IIAEnzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Tissue enhanced
PPP1R14DProtein phosphatase 1 regulatory inhibitor subunit 14DPredicted intracellular proteins
Group enriched
PPP1R1BProtein phosphatase 1 regulatory inhibitor subunit 1BPredicted intracellular proteins
Tissue enhanced
PRAC2Prostate cancer susceptibility candidate 2Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTGDRProstaglandin D2 receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Tissue enhanced
PTPROProtein tyrosine phosphatase, receptor type OCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PYYPeptide YYPredicted secreted proteins
Group enriched
REG4Regenerating family member 4Predicted secreted proteins
Group enriched
REP15RAB15 effector proteinPredicted intracellular proteins
Tissue enhanced
RETNLBResistin like betaPredicted secreted proteins
Tissue enhanced
RXFP4Relaxin/insulin like family peptide receptor 4G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
SAMD13Sterile alpha motif domain containing 13Predicted intracellular proteins
MitochondriaTissue enhanced
SCGNSecretagogin, EF-hand calcium binding proteinPlasma proteins
Predicted intracellular proteins
Tissue enhanced
SEMA4GSemaphorin 4GPlasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Vesicles
Lipid droplets
Tissue enhanced
SLC17A4Solute carrier family 17 member 4Predicted membrane proteins
Transporters
Group enriched
SLC26A2Solute carrier family 26 member 2Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
SLC26A3Solute carrier family 26 member 3Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC28A2Solute carrier family 28 member 2Predicted membrane proteins
Transporters
Tissue enhanced
SLC39A5Solute carrier family 39 member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Vesicles
Cytosol
Group enriched
SLC6A7Solute carrier family 6 member 7Predicted membrane proteins
Transporters
Tissue enhanced
« prev | Page of 4 | next »